LEIDOS BIOMEDICAL RESEARCH INC
Federal contract award, Leidos, $3,707,733
Key CONT_AWD_75N91022F00012_7529_75N91019D00024_7529. First seen by this system September 5, 2026 through the historical sweep, new to the watchlist, public 492 days before this system saw it. One version on record.
Cite this row
3ed85ce7a9b821760df7b2f4c87dfe57ddf977d423fa87b6804a31822d8a120eThe source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.
Versions
| Version | Amount | Change | Occurred | Published | Retrieved | How it arrived | Content hash |
|---|---|---|---|---|---|---|---|
| 1 current | $3,707,733 | first version | September 9, 2022 | May 1, 2025 | 2026-09-05T00:55:32Z | historical sweep | 3ed85ce7a9b8 |
Archived copy
https://web.archive.org/web/20261015124223/https://www.usaspending.gov/award/CONT_AWD_75N91022F00012_7529_75N91019D00024_7529 captured by this system, October 15, 2026
What the amount is made of
4 recorded actions, so the amount is the award's current total across all of them. 2 of them obligated money. Measured 2026-10-10, when USAspending reported a total obligation of $3,707,733.
| Action date | Modification | Type | Obligated | Description as recorded |
|---|---|---|---|---|
| April 30, 2025 | P00003 | TERMINATE FOR CONVENIENCE (COMPLETE OR PARTIAL) | no money | EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI |
| September 17, 2024 | P00002 | OTHER ADMINISTRATIVE ACTION | +$2,805,297 | NIAID DCR OCS-IRF, IRF AIRS TRANSLATION OF 89ZR-DF-IBALIZUMAB |
| December 14, 2022 | P00001 | OTHER ADMINISTRATIVE ACTION | no money | NIAID DCR OCS-IRF, IRF AIRS TRANSLATION OF 89ZR-DF-IBALIZUMAB |
| September 9, 2022 | base | not on file | +$902,436 | NIAID DCR OCS-IRF, IRF AIRS TRANSLATION OF 89ZR-DF-IBALIZUMAB |
Last refreshed November 4, 2026 at 2:31 PM UTC.